Published 17:38 IST, March 18th 2024
AstraZeneca limits out-of-pocket inhaler costs to $35 per month
The $35 cap will be applicable to AstraZeneca's entire respiratory products portfolio, including inhalers used in the treatment of asthma.
![AstraZeneca](https://img.republicworld.com/tr:w-800,h-450,q-75,f-auto/rimages/mika-baumeister-Mtu3Rd1-OBI-unsplash-170141653908616_9.webp)
AstraZeneca | Image:
Unsplash
- Listen to this article
- 1 min read
Advertisement
17:38 IST, March 18th 2024